Evidence map›Paper›PMID 41649948›Full record

SynthesisInternational journal of epidemiology2025

Maternal prenatal infection and childhood leukaemia: a Childhood Cancer and Leukemia International Consortium (CLIC) meta-analysis.

Aurelie Piedvache, Wafaa M Rashed, Eleni Th Petridou, Beth A Mueller, Audrey Bonaventure, Jacqueline Clavel, Adam J de Smith, Michael E Scheurer, John D Dockerty, Catherine Metayer and 21 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in International journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Aurelie PiedvacheDepartment of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.ORCID 0000-0002-2737-0461
Wafaa M RashedPharmacy Practice Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October city, Egypt.ORCID 0000-0001-7531-2840
Eleni Th PetridouDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens & Hellenic Society for Social Pediatrics and Health Promotion, Athens, Greece.ORCID 0000-0003-3695-3439
Beth A MuellerPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Audrey BonaventureEpidemiology of Childhood and Adolescent Cancer Team, CRESS, University Paris Cité, Université Sorbonne Paris Nord, INSERM, INRAE, Villejuif, France.ORCID 0000-0001-6665-8145
Jacqueline ClavelEpidemiology of Childhood and Adolescent Cancer Team, CRESS, University Paris Cité, Université Sorbonne Paris Nord, INSERM, INRAE, Villejuif, France & National Registry of Childhood Cancers, Hôpital Paul Brousse, Groupe Hospitalier Universitaire Paris-Sud, Assistance Publique Hôpitaux de Paris (AP-HP), Villejuif, France & Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre-lès-Nancy, France.ORCID 0000-0002-3616-7676
Adam J de SmithCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, CA, United States.
Michael E ScheurerDepartment of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston, TX, United States.ORCID 0000-0002-8379-6088
John D DockertyDepartment of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Catherine MetayerSchool of Public Health, University of California Berkeley, Berkeley, CA, United States.ORCID 0000-0003-3467-4145
Joseph WiemelsCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, CA, United States.
Alice Y KangSchool of Public Health, University of California Berkeley, Berkeley, CA, United States.
Julia E HeckCollege of Health and Public Service, University of North Texas, Denton, TX, United States.
Johnni HansenDiet, Genes, and Environment section, Danish Cancer Society Research Center, Copenhagen, Denmark.ORCID 0000-0002-9342-2725
Juan Manuel Mejia-ArangureFacultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico & Laboratorio de Genómica Funcional del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Omar Alejandro Sepúlveda-RoblesUnidad de Investigación Médica en Genética Humana, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Maria S Pombo-de-OliveiraDepartment of Research and Technology Innovation (CPQI), Instituto Nacional de Câncer, Rua André Cavalcanti, Rio de Janeiro, Brazil.
Claire Infante-RivardDepartment of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.ORCID 0000-0003-1275-7775
Eve RomanEpidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.ORCID 0000-0001-7603-3704
Friederike ErdmannResearch Group Aetiology and Inequalities in Childhood Cancer, Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0002-9982-3300
Joachim SchüzEnvironment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.ORCID 0000-0001-9687-2134
Mayumi HangaiDepartment of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.
Naho MorisakiDepartment of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.ORCID 0000-0001-6151-4513
David R DoodyPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Janet Flores-LujanoUnidad de Investigación Médica en Genética Humana, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional (CMN) 'Siglo XXI', Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Eric J ChowPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Theodoros N SergentanisDepartment of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece.
Sophia PolychronopoulouDepartment of Pediatric Haematology-Oncology, A. Sophia Children's Hospital, Athens, Greece.
Logan G SpectorDivision of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States.
Kevin Y UrayamaDepartment of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.
NARECHEM-ST

Funding

Maternal comorbidities, prescription drug use in pregnancy and childhood cancerR21CA175959 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HECK, JULIA · 2014 to 2015
$323k
MEXT-Japan Society for the Promotion of Science 26253041NCI NIH HHS R21 CA175959
6 · The paper itself

Abstract

backgroundMaternal prenatal infections may affect fetal development, increasing the immunological vulnerability of offspring to childhood leukaemia (CL). The role of maternal infections in CL is unclear and might vary by subtype (lymphoblastic, ALL; myeloid, AML) or other characteristics. Understanding this potentially modifiable risk factor could inform prevention strategies.

methodsSeventeen hospital- and population-based case-control studies of children born in 1972-2019 within the Childhood Cancer and Leukemia International Consortium with self-questionnaires or health-registry data on maternal infection were included (13 638 cases; 26 870 controls). Meta-analyses assessed CL and maternal infection (overall, viral, bacterial, respiratory, influenza/cold, urinary, genital) stratified by subtype, infection timing, race and ethnicity, and diagnosis age.

resultsThe adjusted meta-analysis odds ratio (OR) for any maternal prenatal infection was 1.13 [95% confidence interval (CI) 0.91-1.40], with similar estimates for ALL and AML. Infection-specific estimates varied. ORs for first-trimester infections were highest for CL and ALL, but not AML, although all CIs contained one. We found modest risk differences between White and Hispanic/Latino children, most notably for CL diagnosed at <2 years (White children: OR 1.25, 95% CI 1.02-1.53; Hispanic/Latino children: OR 0.79, 95% CI 0.34-1.81, subgroup difference P = .05), with similar differences for viral and respiratory/influenza/cold infections.

conclusionAlthough findings only modestly support an association between maternal prenatal infections and CL, some infections might increase the risk more markedly in young White children compared with Hispanic/Latino children. Risk patterns across race and ethnicity, type, and timing of maternal prenatal infection merit further investigation, as do studies with documented exposure information.

Indexed as

LeukemiaPrecursor Cell Lymphoblastic Leukemia-LymphomaPregnancy Complications, InfectiousPrenatal Exposure Delayed EffectsCase-Control StudiesChildChild, PreschoolFemaleHumansInfantLeukemia, Myeloid, AcuteOdds RatioPregnancyRisk Factorscase–control studychildhood leukaemia riskmeta-analysisprenatal infectionrace and ethnicity

Identifiers

PMID41649948
PMCPMC13138385

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.